pharmaphorum November 27, 2023
A comprehensive digital approach to helping patients manage type 2 diabetes, combining continuous glucose monitoring (CGM) devices, wearables and a mobile app, has been shown to improve metabolic health in a large-scale, real-world study.
The programme combines the generative artificial intelligence (genAI) powered January AI app, which acts as a virtual coach, with Abbott’s Freestyle Libre CGM and either an Apple Watch or Fitbit.
It has been put through its paces in a study involving more than 2,200 people – including people with normal range as well as those with prediabetes and full-blown diabetes – that has just been published in the journal Nature Digital Medicine.
The programme is designed to provide patients with lifestyle recommendations via the app...
Today's Sponsors
Today's Sponsor